Elizabeth A. Browning, Ph.D. is a patent agent in the patent counseling and prosecution practice of Dechert’s intellectual property group. Dr. Browning has significant experience assisting clients with patent preparation and prosecution in both the U.S. and internationally.

Dr. Browning focuses her practice on the life sciences and biotechnology industries and has significant experience in the medical imaging and device space. She has prepared and prosecuted patents on a wide range of subject areas including cell-based therapies, therapeutic antibodies and engineered tissues.

Dr. Browning earned her Ph.D. at the University of Virginia, where her doctoral work focused on evaluating shear stress-mediated proinflammatory signal transduction in vascular cells relating to mechanisms of cardiovascular disease. She completed a postdoctoral fellowship at the University of Pennsylvania where her research focused on evaluating the role of ischemia-induced reactive oxygen species in regulating endothelial pro-angiogenic signalling and vascular remodelling.   

Prior to joining Dechert, Dr. Browning worked as a patent agent in the Philadelphia office of a national law firm and as a scientific advisor with an IP boutique law firm. She also worked as the technical director of a preclinical imaging facility at the University of Pennsylvania.

    • Various university and industry clients in the preparation and prosecution of patent applications for both directed to various biotechnologies and related methods of preparation and use, specializing in areas of small molecule therapeutics, cell-based therapies, engineered tissues, various nanotechnologies, imaging probes and reporters, as well as applications directed to medical devices, bioreactors and other engineering designs
    • Various university and industry clients in performing patentability assessment and freedom-to-operate analyses.

    Includes matters handled at Dechert or prior to joining the firm.

    • Chiefs in Intellectual Property (ChIPs), Member